Cancer Vaccines Technologies and Global Markets - PowerPoint PPT Presentation

View by Category
About This Presentation

Cancer Vaccines Technologies and Global Markets


Bharat Book presents the report on “Cancer Vaccines Technologies and Global Markets”(). The report analyzes of the market's dynamics, specifically growth and restriction factors, acquisitions and collaborations, and a look at the cancer vaccine market's current achievements and future challenges. – PowerPoint PPT presentation

Number of Views:35


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Cancer Vaccines Technologies and Global Markets

Cancer Vaccines Technologies and Global Markets
  • The global market for cancer vaccines was valued
    at nearly 4.2 billion and 4.0 billion in 2014
    and 2015, respectively. This market is expected
    to decline from nearly 3.5 billion in 2016 to
    3.4 billion in 2021 at a compound annual growth
    rate (CAGR) of -0.4 for 2016-2021.
  • This report provides
  • An overview of the global markets and
    technologies for cancer vaccines.
  • Analyses of global market trends, with data from
    2014 and 2015, estimates for 2016, and
    projections of CAGRs through 2021.
  • Coverage of the cancer vaccines arena including
    diverse therapeutic platform technologies,
    immune-stimulating agents and approved vaccines
    for cancer.
  • Examination of the governmental and regulatory
    environment and how its effecting the market.
  • Information on new developments including
    products in Phase I-IV clinical trials, as well
    as new technologies.
(No Transcript)
  • According to the World Health Organization,
    cancer has become the leading cause of death in
    recent years. Though cancer vaccines presently
    represent a minor share of the oncology industry,
    they are expected to be one of the most
    profitable segments for pharmaceutical companies
    over the forecast period. Most cancer vaccines
    work by improving a persons immune system,
    allowing it to attack cancer cells, and thus
    virus-induced cancers can be prevented using
    vaccines. Its goal in conducting this study is to
    provide an overview of the current and future
    dynamics of the global market for various cancer
  • This report explores present and future
    strategies within the cancer vaccines market,
    which includes prophylactic vaccines and
    therapeutic vaccines. The development of the
    market, the holdups and the needs of the market
    are discussed in this report. The classifications
    and usage of these vaccines are also discussed in
    this report.
  • Cancer vaccines are an important part of the
    biomedical industry. The sharp rise in cancer
    throughout the world is a consequence of combined
    genetic, social and environmental factors. Thus,
    the need for preventive as well as therapeutic
    vaccines is increasing progressively. Recently,
    some of the vaccines that help protect against
    viral infections have shown promising results to
    prevent some of these viral-induced cancers.
    Modern industries have now begun to explore the
    advantages of cancer vaccines in their
    productions and processes. Many government
    initiatives are encouraging researchers to
    develop cancer immunotherapies.
  • The nature of the disease, expected increase in
    demand for cancer vaccines and higher
    profitability as compared with generic drugs are
    the growth factors of this market.
  • Acquisition strategies and collaborations by
    companies are also covered in this report as well
    as the strengths and weaknesses of each type of
    vaccine in light of the new technologies, growing
    competition, and changing customer needs.
  • This study contributes to the areas of market
    growth for cancer vaccine manufacturers and
    users. Genomic research centers, academic
    institutions, government and private
    laboratories, as well as pharmaceutical,
    diagnostic and biotechnology companies, and
    physicians will find this study to be of
  • The scope of this study entails the global market
    of cancer vaccines. The report covers the total
    market of cancer vaccines, which includes two
    main areas of applications, prophylactic vaccines
    and therapeutic vaccines. Human papillomavirus
    (HPV) vaccines and hepatitis B vaccines that
    indirectly act against cancer are also included
    in the report.
  • The report also covers the global market of
    cancer vaccines by application in various cancer
    types such as prostate, liver, cervical and
    others such as lung and urinary bladder. It is
    discussed from both a commercial perspective and
    that of a research and development (RD)
  • It analyzes each market and its application,
    regulatory environment, new products and
    advancements, market projections and market
  • Both primary and secondary research methodologies
    were used in preparing this study. It conducted a
    comprehensive literature search, which included
    technical newsletters and journals, and many
    other sources. Data were collected through
    interviews and correspondence with manufacturers
    and users of cancer vaccines. Projections were
    based on estimates such as the current number of
    end users, potential end users, mergers and
    acquisitions, and market trends.
  • Many companies were surveyed to obtain data for
    this study. Included were manufacturers and end
    users of cancer vaccines. Data was gathered from
    various industry sources. It spoke with officials
    within the industry, consulted newsletters,
    company literature, product literature, and a
    host of technical articles, journals, indexes,
    and abstracts. Exhaustive investigations of
    databases by key terminology were completed. In
    addition, data were compiled from current
    financial, trade, and government sources.
Table of Contents
  • Introduction
  • Executive Summary
  • Overview
  • Regulatory Aspects
  • New Developments
  • Market Analysis
  • Industry Structure
  • Market By Application
  • Patent Analysis
  • Current Situation
  • Company Profiles
  • Abbreviations
Full Reports
Cancer Vaccines Technologies Global Markets
Bharat Book Bureau Tel 91 22 27810772 /
27810773 Email Website FaceBook BharatBook3B Twitter
ResearchBook LinkedIn Bharat Book Bureau